Select Stock Based Compensation from 2010 to 2024

SEM Stock

USD 38.70 0.97 2.45%

Select Medical Stock Based Compensation yearly trend continues to be very stable with very little volatility. Stock Based Compensation is likely to grow to about 46 M this year. Stock Based Compensation is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. View All Fundamentals

Stock Based Compensation

First Reported

2006-03-31

Previous Quarter

14.4 M

Current Value

13.4 M

Quarterly Volatility

3.7 M

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Select Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Select Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 135.3 M, Interest Expense of 152.3 M or Total Revenue of 4.2 B, as well as many indicators such as Price To Sales Ratio of 0.39, Dividend Yield of 0.021 or PTB Ratio of 2.36. Select financial statements analysis is a perfect complement when working with Select Medical Valuation or Volatility modules.

Check out the analysis of Select Medical Correlation against competitors.

Latest Select Medical's Stock Based Compensation Growth Pattern

Below is the plot of the Stock Based Compensation of Select Medical Holdings over the last few years. It is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. Select Medical's Stock Based Compensation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Select Medical's overall financial position and show how it may be relating to other accounts over time.

Stock Based Compensation

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Stock Based Compensation

Timeline

Select Stock Based Compensation Regression Statistics

	Arithmetic Mean	21,241,030
	Geometric Mean	16,089,083
	Coefficient Of Variation	66.24
	Mean Deviation	11,579,099
	Median	19,284,000
	Standard Deviation	14,069,049
	Sample Variance	197.9T
	Range	42.3M
	R-Value	0.99
	Mean Square Error	5.7T
	R-Squared	0.97
	Slope	3,103,861
	Total Sum of Squares	2771.1T

Select Stock Based Compensation History

	2024	46 M
	2023	43.8 M
	2022	37.8 M
	2021	30.9 M
	2020	27.2 M
	2019	26.5 M
	2018	23.3 M

Other Fundumenentals of Select Medical Holdings

Stock Based Compensation To Revenue

Select Medical Stock Based Compensation component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Good Will	Short Term Investments	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Long Term Debt	Property Plant Equipment	Current Deferred Revenue	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.73	0.97	0.64	0.9	0.98	0.98	0.37	0.99	0.97	0.75	0.89	-0.5	0.97	0.58	0.05	-0.07	0.96	0.32	0.59	-0.24	0.27	0.46	0.8	-0.62	-0.16
Total Stockholder Equity	0.73		0.68	0.7	0.81	0.8	0.73	0.24	0.63	0.67	0.48	0.58	-0.86	0.62	0.44	0.03	0.01	0.7	0.03	0.43	-0.3	0.31	0.13	0.57	-0.52	-0.1
Net Debt	0.97	0.68		0.65	0.9	0.95	0.94	0.5	0.97	0.91	0.76	0.81	-0.4	0.97	0.65	-0.08	0.07	0.95	0.34	0.57	-0.31	0.29	0.31	0.86	-0.71	-0.22
Retained Earnings	0.64	0.7	0.65		0.7	0.7	0.61	0.66	0.57	0.61	0.78	0.43	-0.68	0.59	0.84	-0.26	0.42	0.71	0.38	0.45	-0.75	0.36	0.07	0.82	-0.82	-0.68
Accounts Payable	0.9	0.81	0.9	0.7		0.93	0.89	0.29	0.87	0.85	0.71	0.78	-0.55	0.87	0.49	-0.06	-0.14	0.86	0.23	0.5	-0.41	0.35	0.25	0.77	-0.77	-0.14
Net Receivables	0.98	0.8	0.95	0.7	0.93		0.96	0.4	0.95	0.95	0.74	0.85	-0.57	0.94	0.6	-0.05	-0.01	0.95	0.26	0.56	-0.34	0.34	0.39	0.8	-0.65	-0.17
Good Will	0.98	0.73	0.94	0.61	0.89	0.96		0.32	0.97	0.94	0.65	0.94	-0.53	0.98	0.57	0.02	-0.12	0.95	0.28	0.64	-0.18	0.3	0.4	0.75	-0.57	-0.16
Short Term Investments	0.37	0.24	0.5	0.66	0.29	0.4	0.32		0.36	0.31	0.53	0.13	-0.21	0.42	0.91	-0.53	0.87	0.5	0.29	0.29	-0.56	0.2	-0.2	0.75	-0.56	-0.75
Total Liab	0.99	0.63	0.97	0.57	0.87	0.95	0.97	0.36		0.97	0.74	0.9	-0.4	0.99	0.56	0.05	-0.1	0.94	0.35	0.58	-0.19	0.24	0.49	0.79	-0.6	-0.16
Total Current Assets	0.97	0.67	0.91	0.61	0.85	0.95	0.94	0.31	0.97		0.78	0.86	-0.46	0.93	0.52	0.13	-0.11	0.9	0.34	0.51	-0.27	0.2	0.63	0.75	-0.56	-0.13
Short Term Debt	0.75	0.48	0.76	0.78	0.71	0.74	0.65	0.53	0.74	0.78		0.55	-0.37	0.69	0.68	0.0	0.2	0.71	0.43	0.47	-0.58	0.35	0.48	0.82	-0.73	-0.49
Intangible Assets	0.89	0.58	0.81	0.43	0.78	0.85	0.94	0.13	0.9	0.86	0.55		-0.44	0.91	0.4	0.07	-0.31	0.83	0.13	0.73	0.0	0.44	0.42	0.54	-0.38	-0.05
Common Stock	-0.5	-0.86	-0.4	-0.68	-0.55	-0.57	-0.53	-0.21	-0.4	-0.46	-0.37	-0.44		-0.4	-0.46	-0.13	-0.09	-0.53	0.12	-0.35	0.19	-0.32	-0.08	-0.4	0.32	0.32
Long Term Debt	0.97	0.62	0.97	0.59	0.87	0.94	0.98	0.42	0.99	0.93	0.69	0.91	-0.4		0.61	-0.05	-0.04	0.96	0.32	0.61	-0.23	0.27	0.37	0.8	-0.62	-0.21
Property Plant Equipment	0.58	0.44	0.65	0.84	0.49	0.6	0.57	0.91	0.56	0.52	0.68	0.4	-0.46	0.61		-0.43	0.69	0.71	0.39	0.48	-0.56	0.32	-0.05	0.85	-0.68	-0.81
Current Deferred Revenue	0.05	0.03	-0.08	-0.26	-0.06	-0.05	0.02	-0.53	0.05	0.13	0.0	0.07	-0.13	-0.05	-0.43		-0.52	-0.08	-0.2	-0.05	0.36	-0.32	0.58	-0.28	0.33	0.38
Net Tangible Assets	-0.07	0.01	0.07	0.42	-0.14	-0.01	-0.12	0.87	-0.1	-0.11	0.2	-0.31	-0.09	-0.04	0.69	-0.52		0.1	0.14	0.0	-0.45	0.08	-0.39	0.39	-0.24	-0.66
Long Term Debt Total	0.96	0.7	0.95	0.71	0.86	0.95	0.95	0.5	0.94	0.9	0.71	0.83	-0.53	0.96	0.71	-0.08	0.1		0.31	0.55	-0.32	0.29	0.31	0.84	-0.67	-0.29
Capital Surpluse	0.32	0.03	0.34	0.38	0.23	0.26	0.28	0.29	0.35	0.34	0.43	0.13	0.12	0.32	0.39	-0.2	0.14	0.31		0.04	-0.38	-0.32	0.31	0.56	-0.58	-0.41
Deferred Long Term Liab	0.59	0.43	0.57	0.45	0.5	0.56	0.64	0.29	0.58	0.51	0.47	0.73	-0.35	0.61	0.48	-0.05	0.0	0.55	0.04		-0.14	0.7	0.05	0.38	-0.28	-0.17
Long Term Investments	-0.24	-0.3	-0.31	-0.75	-0.41	-0.34	-0.18	-0.56	-0.19	-0.27	-0.58	0.0	0.19	-0.23	-0.56	0.36	-0.45	-0.32	-0.38	-0.14		-0.13	0.07	-0.58	0.75	0.5
Short Long Term Debt	0.27	0.31	0.29	0.36	0.35	0.34	0.3	0.2	0.24	0.2	0.35	0.44	-0.32	0.27	0.32	-0.32	0.08	0.29	-0.32	0.7	-0.13		-0.23	0.15	-0.15	-0.1
Cash And Equivalents	0.46	0.13	0.31	0.07	0.25	0.39	0.4	-0.2	0.49	0.63	0.48	0.42	-0.08	0.37	-0.05	0.58	-0.39	0.31	0.31	0.05	0.07	-0.23		0.2	0.01	0.14
Net Invested Capital	0.8	0.57	0.86	0.82	0.77	0.8	0.75	0.75	0.79	0.75	0.82	0.54	-0.4	0.8	0.85	-0.28	0.39	0.84	0.56	0.38	-0.58	0.15	0.2		-0.87	-0.6
Net Working Capital	-0.62	-0.52	-0.71	-0.82	-0.77	-0.65	-0.57	-0.56	-0.6	-0.56	-0.73	-0.38	0.32	-0.62	-0.68	0.33	-0.24	-0.67	-0.58	-0.28	0.75	-0.15	0.01	-0.87		0.54
Capital Stock	-0.16	-0.1	-0.22	-0.68	-0.14	-0.17	-0.16	-0.75	-0.16	-0.13	-0.49	-0.05	0.32	-0.21	-0.81	0.38	-0.66	-0.29	-0.41	-0.17	0.5	-0.1	0.14	-0.6	0.54

Click cells to compare fundamentals

About Select Medical Financial Statements

Select Medical investors utilize fundamental indicators, such as Stock Based Compensation, to predict how Select Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.

	Last Reported	Projected for Next Year
Stock Based Compensation	43.8 M	46 M
Stock Based Compensation To Revenue	0.01	0.01

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Select Medical Holdings is a strong investment it is important to analyze Select Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Select Medical's future performance. For an informed investment choice regarding Select Stock, refer to the following important reports:

How To Invest In Select

Details

Is Select Stock a good investment?

Details

What is Select Medical's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out the analysis of Select Medical Correlation against competitors.

You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Select Medical. If investors know Select will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Select Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.139

Dividend Share

0.5

Earnings Share

2.14

Revenue Per Share

56.158

Quarterly Revenue Growth

0.057

The market value of Select Medical Holdings is measured differently than its book value, which is the value of Select that is recorded on the company's balance sheet. Investors also form their own opinion of Select Medical's value that differs from its market value or its book value, called intrinsic value, which is Select Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Select Medical's market value can be influenced by many factors that don't directly affect Select Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Select Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Select Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Select Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Select Stock Based Compensation from 2010 to 2024

Latest Select Medical's Stock Based Compensation Growth Pattern

Select Stock Based Compensation Regression Statistics

Select Stock Based Compensation History

Other Fundumenentals of Select Medical Holdings

Select Medical Stock Based Compensation component correlations

About Select Medical Financial Statements

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY